Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.215 USD | +3.06% |
|
-7.93% | -72.05% |
06-20 | UBS Downgrades Zentalis Pharmaceuticals to Neutral From Buy, Adjusts Price Target to $5 From $28 | MT |
06-18 | US Equity Markets Close Up Tuesday Following Less-Than-Expected Retail Sales Growth | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-72.05% | 290M | |
+15.84% | 121B | |
+19.76% | 113B | |
+17.47% | 26.02B | |
-25.02% | 19.39B | |
-19.51% | 15.91B | |
-17.89% | 15.09B | |
-46.87% | 15.06B | |
+63.22% | 14.93B | |
+5.57% | 13.85B |
- Stock Market
- Equities
- ZNTL Stock
- News Zentalis Pharmaceuticals, Inc.
- Westport Brief: Announcing Resignation of David Johnson, Chief Executive Officer, and Names Interim CEO